
Shanghai Yizhong Pharmaceutical Co., Ltd.
SSE:688091.SS
44.59 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 71.032 | 4.739 | 47.451 | 52.964 | 68.379 | 80.687 | 78.771 | 108.031 | 92.4 | 69.634 | 94.453 | 37.529 | 34.342 | 4.078 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 13.222 | 4.035 | 2.596 | 2.969 | 3.733 | 4.798 | 5.035 | 6.773 | 7.103 | 5.178 | 6.258 | 3.216 | 2.318 | 0.296 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 57.81 | 0.704 | 44.855 | 49.995 | 64.646 | 75.889 | 73.737 | 101.258 | 85.296 | 64.456 | 88.194 | 34.313 | 32.024 | 3.782 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.814 | 0.149 | 0.945 | 0.944 | 0.945 | 0.941 | 0.936 | 0.937 | 0.923 | 0.926 | 0.934 | 0.914 | 0.933 | 0.927 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 9.277 | 11.86 | 10.014 | 9.734 | 5.596 | 5.743 | 7.722 | 6.382 | 2.603 | 3.177 | 2.21 | 1.082 | 1.456 | 0.304 | 3.857 | 5.236 | 3.843 | 5.417 | 4.235 | 3.569 | 4.673 |
General & Administrative Expenses
| 6.214 | -15.216 | 16.887 | 5.866 | 8.375 | 5.228 | 13.469 | 6.259 | 8.548 | -2.83 | 5.334 | -0.945 | 2.223 | -6.619 | 10.586 | 2.861 | 3.149 | -4.55 | 7.275 | 0.737 | 0.747 |
Selling & Marketing Expenses
| 28.209 | -17.268 | 45.367 | 27.905 | 25.582 | 27.857 | 30.247 | 33.744 | 14.786 | 29.556 | 48.062 | 6.64 | 4.773 | 1.824 | 0.494 | 0 | -0 | 0 | 0 | 0 | 0 |
SG&A
| 34.423 | -36.892 | 62.292 | 38.699 | 33.399 | 40.821 | 43.716 | 40.003 | 23.334 | 26.726 | 53.396 | 5.695 | 6.996 | -4.795 | 11.08 | 2.861 | 3.149 | -4.55 | 7.275 | 0.737 | 0.747 |
Other Expenses
| -2.387 | 46.645 | -27.076 | -2.634 | -0.976 | -0.037 | -2.667 | -1.275 | 0.14 | -3.547 | -3.382 | 2.982 | -0.214 | 3.783 | -4.807 | -6.722 | -5.504 | 7.676 | -0.001 | 1.441 | -0.005 |
Operating Expenses
| 41.313 | 18.002 | 45.23 | 48.433 | 38.995 | 46.601 | 48.598 | 49.625 | 26.077 | 26.356 | 52.224 | 9.759 | 8.238 | -0.709 | 10.131 | -6.722 | -5.504 | 8.543 | 6.26 | 5.746 | 7.087 |
Operating Income
| 16.498 | -10.674 | -6.999 | 1.562 | 25.651 | 29.288 | 32.887 | 58.008 | 66.146 | 46.921 | 43.918 | 30.917 | 29.832 | 11.442 | -8.498 | -6.722 | -5.504 | -7.165 | -4.743 | -4.364 | -5.569 |
Operating Income Ratio
| 0.232 | -2.252 | -0.147 | 0.029 | 0.375 | 0.363 | 0.417 | 0.537 | 0.716 | 0.674 | 0.465 | 0.824 | 0.869 | 2.806 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -1.008 | -7.275 | 6.161 | -2.634 | -0.976 | 6.337 | 5.081 | -1.275 | -1.824 | -0.608 | -0.695 | -0.723 | 0 | -0.6 | 0.6 | 0 | 0 | 0 | -0.001 | 0 | -0.005 |
Income Before Tax
| 15.49 | -33.282 | -0.837 | 5.467 | 33.469 | 35.624 | 30.219 | 56.734 | 64.323 | 46.313 | 43.223 | 30.194 | 29.832 | 10.842 | -7.898 | -6.722 | -5.504 | -7.165 | -4.744 | -4.364 | -5.574 |
Income Before Tax Ratio
| 0.218 | -7.023 | -0.018 | 0.103 | 0.489 | 0.442 | 0.384 | 0.525 | 0.696 | 0.665 | 0.458 | 0.805 | 0.869 | 2.659 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 1.304 | -5.588 | -0.998 | 0.137 | 4.291 | 4.694 | 3.705 | 7.649 | 9.298 | 7.624 | 0.036 | -0.041 | -0.913 | -4.857 | 1.633 | 7.945 | -0.054 | 1.378 | 1.517 | -0.535 | 0.081 |
Net Income
| 14.186 | -27.695 | 0.161 | 5.331 | 29.178 | 30.93 | 26.514 | 49.085 | 55.025 | 38.689 | 43.187 | 30.235 | 30.744 | 16.127 | -7.898 | -6.722 | -5.504 | -7.165 | -4.744 | -4.364 | -5.574 |
Net Income Ratio
| 0.2 | -5.844 | 0.003 | 0.101 | 0.427 | 0.383 | 0.337 | 0.454 | 0.596 | 0.556 | 0.457 | 0.806 | 0.895 | 3.955 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| 0.07 | -0.177 | 0.001 | 0.026 | 0.18 | 0.2 | 0.17 | 0.31 | 0.35 | 0.24 | 0.41 | 0.29 | 0.21 | 0.19 | -0.099 | -0.084 | -0.047 | -0.09 | -0.06 | -0.055 | -0.052 |
EPS Diluted
| 0.07 | -0.177 | 0.001 | 0.026 | 0.18 | 0.2 | 0.17 | 0.31 | 0.35 | 0.24 | 0.41 | 0.29 | 0.21 | 0.19 | -0.099 | -0.084 | -0.047 | -0.09 | -0.06 | -0.055 | -0.052 |
EBITDA
| 14.212 | -27.801 | -0.731 | 8.636 | 36.578 | 38.005 | 32.641 | 58.551 | 66.154 | 47.932 | 45.334 | 31.788 | 31.426 | 11.015 | -7.584 | -11.996 | -5.504 | -9.391 | -5.443 | -4.233 | -5.507 |
EBITDA Ratio
| 0.2 | -5.866 | -0.015 | 0.163 | 0.535 | 0.471 | 0.414 | 0.542 | 0.716 | 0.688 | 0.48 | 0.847 | 0.915 | 2.701 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |